Long-Term Side Effects of Disulfiram (Antabuse)
Disulfiram should be avoided in patients with severe liver disease due to the risk of potentially fatal hepatotoxicity, and long-term use carries risks of peripheral neuropathy, optic neuritis, and hepatic failure that require ongoing monitoring.
Hepatotoxicity: The Most Serious Long-Term Risk
The most concerning long-term side effect of disulfiram is hepatotoxicity, including hepatic failure that can result in transplantation or death 1, 2. This risk is particularly important because:
- Fatal hepatitis occurs in approximately 1 in 25,000-30,000 treatment-years 3, 4
- Hepatotoxicity can develop even after many months of therapy 2
- It occurs in patients with or without prior history of abnormal liver function 2
- The onset typically peaks around 2 months after starting treatment, though it can occur from 15 days to 6 months 4, 5
Critical monitoring requirement: Baseline and follow-up liver function tests every 10-14 days are essential 2. Patients must immediately report early symptoms of hepatitis: fatigue, weakness, malaise, anorexia, nausea, vomiting, jaundice, or dark urine 2.
Neurological Complications
Peripheral Neuropathy
Dose-dependent peripheral neuropathy is a well-documented long-term complication 3, 4, 5. This can present as:
- Sensory deficits
- Motor deficits
- Combined sensorimotor polyneuropathy
- Rare cases of tetraplegia 5
The rate of neurological adverse events increases with duration of therapy 4, making this a true long-term concern rather than an acute reaction.
Optic Neuritis
Severe optic neuritis has been reported with long-term use 3, 5, 6. While typically reversible within 2 months of discontinuation 5, this can cause:
- Gradual bilateral vision loss
- Central-caecal scotomata
- Swollen optic nerve heads 6
Monitoring recommendation: Annual ophthalmic reviews with visual field testing for patients on long-term therapy 6.
Psychiatric and Cognitive Effects
Long-term disulfiram use can cause:
- Psychosis and confusional states (rare) 3
- Encephalopathy (frequently associated with other toxic symptoms) 5
- These effects appear more common in certain populations, with higher rates reported in India than Western countries 3
Common but Less Severe Long-Term Effects
The most frequent ongoing side effects include 3:
- Tiredness
- Headache
- Sleepiness
- Dizziness and fatigue (particularly in initial phases but can persist) 7
Important Drug Interactions
Disulfiram inhibits cytochrome P450 metabolism, leading to clinically significant long-term interactions 2, 3, 4:
- Phenytoin: Can lead to phenytoin intoxication; requires baseline levels and ongoing monitoring 2
- Oral anticoagulants: Prolongs prothrombin time; dosage adjustment needed 2
- Isoniazid: Can cause unsteady gait or marked mental status changes 2
Safety Profile Context
Despite these risks, the overall safety profile shows:
- Intermediate rate of adverse reactions (1 per 200-2,000 treatment-years) 4
- In supervised long-term treatment (mean 70 months), tolerability was considered high with no serious adverse events in one case series 7
- Deaths from disulfiram-alcohol reactions have not been reported in recent years, likely due to lower dosages and exclusion of cardiac patients 3
Clinical Decision Algorithm
Contraindications for long-term use:
- Severe alcoholic liver disease 1, 8
- History of cardiac disease
- Pre-existing peripheral neuropathy or optic neuritis
- Hepatic dysfunction
If prescribing long-term:
- Obtain baseline liver function tests, complete blood count, serum chemistries
- Monitor liver enzymes every 10-14 days initially, then regularly 2
- Perform neurological examination monthly 5
- Conduct ophthalmological examination every 2 months 5
- Ensure supervised administration to maximize compliance and safety 7
Alternative agents to consider: For patients with liver disease, baclofen is the only medication tested in randomized trials for alcohol-dependent patients with cirrhosis and may be safer 8. Acamprosate has no hepatic metabolism and no reported hepatotoxicity 8.